ERoad (ASX:ERD) posts NZ$161m FY26 loss after North America write-down, but ANZ momentum and the eRUC opportunity in New Zealand look promising in FY27.
Small Caps Stocks
The Environmental Group (ASX:EGL) cut FY26 EBITDA guidance to A$8.5m-A$9.0m on ERP issues at Energy and Suez Canal delays at Baltec.
Arafura Rare Earths (ASX:ARU) launches A$350m placement at A$0.260 after Nolans FID, lifting pro forma cash to A$911m and clearing equity funding.
Ainsworth Game Technology (ASX:AGI) flagged a A$1 million H1CY26 pre-tax profit as North American revenue slid 24%.
Appen (ASX:APX) has given FY26 revenue guidance of US$270m to US$300m as the AI data turnaround takes hold.
Tivan (ASX:TVN) just signed Binding Term Sheets with Timor-Leste state miner Murak Rai for Baucau and Ossu copper-gold projects, with maiden Ossu drilling set for Q4 2026.
Helix Resources (ASX:HLX) has acquired 50% of the Weerianna Gold-Lithium Project in the West Pilbara, 4km from the Andover discovery.
Oceania Healthcare (ASX:OCA) delivered FY26 EBITDA up 20% and cut net debt by NZ$121m, but pulled the dividend until cash flow turns positive.
MaxiPARTS (ASX:MXI) held its FY26 underlying profit guidance despite a Middle East driven activity slowdown that softens revenue to $273m to $278m.
Avecho Biotechnology (ASX:AVE) has locked in 244 patients for its Phase III insomnia interim analysis, with the late June 2026 readout now a hard date.
